在肺移植中治疗慢性肺异质移植功能障碍的Everolimus治疗
David Iturbe-Fernández1, Alicia de Pablo Gafas2, Víctor Manuel Mora Cuesta1
1Lung Transplant Unit, Pulmonary Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
Life (Basel, Switzerland)
|May 25, 2024
概括
埃弗罗利莫斯治疗可能会减缓肺部功能下降的肺部移植接受者慢性肺部异位移植功能障碍. 然而,大量患者因不良事件而停止服用药物.
科学领域:
- 肺部病理学 肺部病理学
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性肺异位移植功能障碍 (CLAD) 是肺移植接受者长期发病和死亡的主要原因.
- 作为一种mTOR抑制剂的Everolimus已经显示出在治疗各种移植后并发症方面的潜力.
研究的目的:
- 评估Everolimus在被诊断患有CLAD的肺移植患者改善肺功能方面的疗效.
- 评估everolimus在这个患者群体中的安全性和耐受性.
主要方法:
- 在2008年10月至2016年10月期间,对肺移植 (LT) 患者进行回顾性分析,这些患者接受了Everolimus治疗的CLAD.
- 在开始服用everolimus之前和之后,评估一秒钟内强迫呼气体积 (FEV1) 的变化.
- 监测膜过率 (GFR) 以评估功能.
主要成果:
- 治疗Everolimus与FEV1下降率在开始后12个月内显著降低相关 (p <0.05).
- 在整个研究期间,淋巴膜过率保持稳定,这表明对功能没有显著影响.
- 很大一部分患者 (38.6%) 停止服用埃弗罗利莫斯,平均停药时间为14.1个月.
结论:
- 埃弗罗利斯在患有CLAD的肺移植接受者中减缓FEV1下降具有有益作用.
- 尽管有潜在的益处,但药物戒断率高,需要对患者进行仔细的选择和对不良事件的监测.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...


